Intravaginal 6.5mg prasterone administration in postmenopausal women with overactive bladder syndrome: a pilot study
Keyword(s):
2021 ◽
Vol 24
(3)
◽
pp. 284-293
2018 ◽
Vol 7
(51)
◽
pp. 5440-5446
◽
2020 ◽
Vol 30
(06)
◽
pp. 622-626
2016 ◽
Vol 214
(4)
◽
pp. S496